USPTO serial 79279268
VERI-Q
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 25, 2021
- Examiner
- TRUSILO, KELLY JEAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with VERI-Q?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sang Ho Lee
Sang Ho Lee Bridgeway IP Law Group, PLLC11350 Random Hills RdSuite 800Fairfax, VA 22030Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes; reagents for nucleic acid amplifications for scientific or laboratory purposes; reagents for nucleic acid amplification, other than for medical purposes; chemical reagents for use in genetic research, namely, genetic identity testing | ACTIVE | — |
| 005 | Diagnostic test reagents for medical or veterinary purposes; medical diagnostic test strips; reagent paper for medical purposes; diagnostic test reagents for medical purposes; reagents for use in medical genetic testing; chemical preparations for use in DNA medical analysis; biological preparations for the prevention and treatment of infectious diseases, tropical fever disease, and food pathogen disease; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, tear production in dry eyes, and for blood glucose levels | ACTIVE | — |
| 009 | Laboratory apparatus, namely, reagent cartridges used for extracting and analyzing DNA, reagent containers used for DNA analysis apparatus, DNA analysis apparatus, gene analyzing and extracting devices, devices for analyzing polynucleic acid sequence, devices for analyzing gene information, DNA sequencing devices, devices for analyzing protein sequence, reagent cartridges used for protein analysis apparatus, reagent containers used for protein analysis apparatus, diagnostic apparatus for use in the detection of pathogens for laboratory or research use, all of the foregoing not for medical purposes; gene amplifiers; DNA chips; DNA microarray used for scientific or laboratory research; biochips for research or scientific purposes; biochip analyzing apparatus, namely, gene amplifiers, and laboratory gene analyzing and extracting devices; computer programs, recorded for editing images, sound, and video, for use in database management, and for use in electronic storage of data; computer programs, downloadable for use in database management, use in electronic storage of data, use as a spread sheet, and word processing; computer software applications, downloadable for use in database management, and use in electronic storage of data; plate for analyzing genes for research or scientific purposes; multiple well plates for use in the sample preparation and purification of DNA samples for research or scientific purposes; micromulti-well plates which can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research | ACTIVE | — |
| 010 | Diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, DNA, RNA, or for measuring blood sugar, blood and blood components, and glycated hemoglobin; cholesterol measuring apparatus for medical purposes; apparatus for clinical diagnosis for measuring diabetes, measuring glycated hemoglobin, measuring blood, counting blood cell, and for testing DNA and RNA; apparatus for magnet therapy; haemocytometers; devices for measuring blood sugar; filters for blood and blood components; blood testing apparatus; apparatus for blood analysis; apparatus for taking blood samples; diabetes measuring apparatus; glycated hemoglobin measuring apparatus; lancets; apparatus for DNA and RNA testing for medical purposes; immunofluorescence analysis apparatus for medical purposes being immunoassay analyzers for medical diagnostic uses; medical health signal measuring instruments in the nature of instruments for measuring pulse, electrocardiogram, blood components, blood pressure, heart rate, body temperature, body mass, body fat, and blood glucose; chromatographic instruments for medical use, namely, instruments for measuring amino acid, hormone, and protein; medical devices for obtaining body fluid sample for analysis; measuring instruments for medical purposes, namely, instruments for measuring blood pressure, cholesterol, blood glucose, cardiac output, lung capacity, and other physiological and cardiovascular parameters; cartridges for medical purposes, namely, containers for gas, liquid, and gel sold empty for medical use; medical apparatus for diagnostic use in the field of infectious diseases, tropical fever disease, and food pathogen disease, namely, well plates for enzyme linked immunosorbent assay and well plate for polymerase chain reaction | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MiCo BioMed Co., Ltd.
- Other trademarks owned by MiCo BioMed Co., Ltd.
- Other trademarks owned by MiCo BioMed Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named VERI-Q
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 25, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 6, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 6, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 27, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 10, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 10, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 25, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 25, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 7, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 29, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 28, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2021 | ALIE | ASSIGNED TO LIE | — |
| Oct 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 14, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 14, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 27, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 26, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 29, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 25, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 20, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |